切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2019, Vol. 15 ›› Issue (01) : 14 -18. doi: 10.3877/cma.j.issn.1673-5250.2019.01.003

所属专题: 文献

论著

妊娠期糖尿病孕妇晚孕期血脂浓度检测的临床意义
韩肖燕1, 杨惠霞2, 杨桦1,()   
  1. 1. 首都医科大学附属北京友谊医院妇产科 100050
    2. 首都医科大学附属北京康复医院 100144
  • 收稿日期:2018-10-09 修回日期:2019-01-02 出版日期:2019-02-01
  • 通信作者: 杨桦

Clinical significance of blood lipids detection in the third trimester pregnant women with gestational diabetes mellitus

Xiaoyan Han1, Huixia Yang2, Hua Yang1,()   

  1. 1. Department of Obstetrics and Gynecology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
    2. Beijing Rehabilitation Hospital of Capital Medical University, Beijing 100144, China
  • Received:2018-10-09 Revised:2019-01-02 Published:2019-02-01
  • Corresponding author: Hua Yang
  • About author:
    Corresponding author: Yang Hua, Email:
  • Supported by:
    Scientific Research Project of Clinical Medicine by Beijing Medical Association(2018-P2-010-01)
引用本文:

韩肖燕, 杨惠霞, 杨桦. 妊娠期糖尿病孕妇晚孕期血脂浓度检测的临床意义[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(01): 14-18.

Xiaoyan Han, Huixia Yang, Hua Yang. Clinical significance of blood lipids detection in the third trimester pregnant women with gestational diabetes mellitus[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2019, 15(01): 14-18.

目的

探讨妊娠期糖尿病(GDM)孕妇晚孕期血脂浓度检测的临床价值。

方法

选择2017年1月至12月,于首都医科大学附属北京友谊医院产科门诊接受产前检查的108例晚孕期GDM孕妇为研究对象,纳入观察组。采用随机数字表法,选择同期在同一家医院接受产前检查的晚孕期健康孕妇108例,纳入对照组。采用成组t检验,对2组晚孕期孕妇血脂指标,如血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)及高密度脂蛋白胆固醇(HDL-C)浓度进行比较。根据观察组GDM孕妇孕期的体重增加值,将其进一步分为体重增加过多亚组、体重增加合适亚组、体重增加不足亚组。采用单因素方差分析,对观察组3个亚组GDM孕妇晚孕期血脂浓度进行比较。本研究遵循的程序符合首都医科大学附属北京友谊医院人体试验委员会所制定的伦理学标准,得到该委员会批准(审批文号:2017-9-1),分组征得受试者本人的知情同意,并与之签署临床研究知情同意书。

结果

①观察组与对照组孕妇年龄、孕龄及孕期体重增加值比较,差异均无统计学意义(P>0.05)。②观察组GDM孕妇晚孕期血清TC、TG、LDL-C浓度,分别为(7.49±0.69)、(3.64±0.56)、(3.93±0.49) mmol/L,均分别显著高于对照组的(5.52±0.41)、(2.13±0.39)、(2.81±0.17) mmol/L,而血清HDL-C浓度为(1.62±0.22) mmol/L,显著低于对照组的(1.96±0.16) mmol/L,2组分别比较,差异均有统计学意义(t=5.463,P<0.001;t=4.981,P<0.001;t=4.795,P<0.001;t=-2.736,P=0.007)。③根据观察组108例GDM孕妇孕期的体重增加值,将其分为体重增加过多亚组、体重增加合适亚组、体重增加不足亚组,分别为38、42及28例。观察组3个亚组GDM孕妇晚孕期血清TC、TG及LDL-C浓度分别比较,差异均有统计学意义(F=8.587,P=0.020;F=6.164,P=0.030;F=14.266,P=0.001),并且体重增加过多亚组孕妇上述3个指标均为最高。但是,3个亚组GDM孕妇晚孕期血清HDL-C浓度比较,差异无统计学意义(P>0.05)。

结论

GDM孕妇更容易发生脂代谢异常,尤其是孕期体重增加过多的GDM孕妇,其晚孕期血脂浓度更高。产科医师应加强对GDM孕妇进行合理营养饮食的宣传教育及孕期体重管理,这不仅有利于降低GDM孕妇晚孕期血脂浓度,还有利于减少其围生期并发症及不良妊娠结局的发生。

Objective

To study the clinical values of blood lipids concentrations detection in the third trimester pregnant women with gestational diabetes mellitus (GDM).

Methods

From January to December 2017, a total of 108 pregnant women in the third trimester who were diagnosed as GDM during routine prenatal care in Beijing Friendship Hospital, Capital Medical University were selected as research subjects and enrolled into observation group. Meanwhile, another 108 healthy pregnant women in the third trimester who received routine prenatal care in the same hospital during the same period were included into control group by random number table method. Concentrations of blood lipid indexes, such as serum total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C) were compared by independent-samples t test between two groups. According to gestational weight gain of GDM pregnant women in observation group, they were further divided into excessive weight gain subgroup, appropriate weight gain subgroup and underweight gain subgroup, and concentrations of blood lipid indexes among these three subgroups were compared by one-ANOVA method. This study protocol was in line with the Institutional Review Board of Beijing Friendship Hospital, Capital Medical University (Approval No. 2017-9-1), and clinical research consents were obtained from all participants.

Results

①There were no significant differences in age, gestational age and gestational weight gain between observation group and control group (P>0.05). ②Serum concentrations of TC, TG and LDL-C in observation group were (7.49±0.69) mmol/L, (3.64±0.56) mmol/L and (3.93±0.49) mmol/L, respectively, which were significantly higher than those (5.52±0.41) mmol/L, (2.13±0.39) mmol/L and (2.81±0.17) mmol/L, respectively in control group; but serum concentration of HDL-C in observation group was (1.62±0.22) mmol/L, which was significantly lower than that (1.96±0.16) mmol/L in control group, and all differences of serum concentrations of blood lipid indexes between observation group and control group were statistically significant (t=5.463, P<0.001; t=4.981, P<0.001; t=4.795, P<0.001; t=-2.736, P=0.007). ③Among the 108 pregnant women in the third trimester with GDM of observation group, 38, 42, and 28 cases were divided into excessive weight gain subgroup, appropriate weight gain subgroup and underweight gain subgroup, respectively. There were statistically significant differences among three subgroups in serum concentrations of TC, TG and LDL-C (F=8.587, P=0.020; F=6.164, P=0.030; F=14.266, P=0.001), and these three blood lipid indexes in excessive weight gain subgroup all were higher than those in appropriate weight gain subgroup and underweight gain subgroup. But there was no significant difference in serum concentration of HDL-C among three subgroups (P>0.05).

Conclusions

GDM women are more likely to have abnormal blood lipid metabolism, especially in those who have excessive gestational weight gain, and their serum concentrations of blood lipid indexes, such as serum concentrations of TC, TG and LDL-C are much higher in the third trimester pregnancy compared with healthy pregnant women. Obstetricians should strengthen the education of rational nutrition diet and weight management in GDM women, which not only helps to reduce serum concentrations of blood lipid indexes, such as serum concentrations of TC, TG and LDL-C of pregnant women with GDM in the third trimester, but also helps to reduce the incidences of perinatal complications and adverse pregnancy outcomes.

表1 观察组与对照组晚孕期孕妇一般临床资料比较(±s)
表2 观察组与对照组孕妇晚孕期血脂指标比较(mmol/L,±s)
表3 观察组3个亚组妊娠期糖尿病孕妇晚孕期血脂指标比较(mmol/L,±s)
[1]
Ryckman KK, Spracklen CN, Smith CJ, et al. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and Meta-analysis[J]. BJOG, 2015, 122(5): 643-651.
[2]
Pinney SE, Simmons RA. Metabolic programming, epigenetics, and gestational diabetes mellitus [J]. Curr Diab Rep, 2012, 12(1): 67-74.
[3]
王晨,杨慧霞.孕期运动在妊娠期糖尿病预防和管理中的作用 [J/CD].中华妇幼临床医学杂志(电子版),2014,10(5): 676-679.
[4]
Wang C, Zhu WW, Wei YM, et al. The predictive effects of early pregnancy lipid profiles and fasting glucose on the risk of gestational diabetes mellitus stratified by body mass index[J]. J Diabetes Res, 2016, 2016: 3013567.
[5]
李立红,韩利红,乔爱琴.妊娠期糖尿病患者血糖、血脂水平与新生儿体质量的关系[J].海南医学院学报,2014,20(10): 1417-1418,1421.
[6]
孔令英,杨慧霞.妊娠期糖尿病孕妇血脂变化与胎盘脂质转运 [J/CD].中华妇幼临床医学杂志(电子版),2013,9(1): 5-9.
[7]
胡小月,霍琰.脂代谢与妊娠期并发症研究新进展[J].中国计划生育和妇产科,2018,10(1): 15-18.
[8]
Bao W, Dar S, Zhu Y, et al. Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus: a longitudinal study[J]. J Diabetes, 2017, 10(6): 487-495.
[9]
dos Santos-Weiss IC, Réa RR, Fadel-Picheth CM, et al. The plasma logarithm of the triglyceride/HDL-cholesterol ratio is a predictor of low risk gestational diabetes in early pregnancy[J]. Clin Chim Acta, 2013, 418(1): 1-4.
[10]
Ismail NA, Kasim MM, Noor Aizuddin A, et al. Homeostatic indices of insulin resistance among gestational diabetics in anticipating pregnancy complications[J]. Gynecol Endocrinol, 2013, 29(7): 691-694.
[11]
Cao WP, Wang X, Chen T, et al. Maternal lipids, BMI and IL-17/IL-35 imbalance in concurrent gestational diabetes mellitus and preeclampsia[J]. Exp Ther Med, 2018, 16(1): 427-435.
[12]
Qiu X, Gao F, Qiu Y, et al. Association of maternal serum homocysteine concentration levels in late stage of pregnancy with preterm births: a nested case-control study[J]. J Matern Fetal Neonatal Med, 2018, 31(20): 2673-2677.
[13]
Lambrinoudaki I, Vlachou SA, Creatsas G. Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment[J]. Curr Diabetes Rev, 2010, 6(6): 393-399.
[14]
Vrachnis N, Belitsos P, Sifakis S, et al. Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus[J]. Int J Endocrinol, 2012, 2012: 549748.
[15]
Shen H, Liu X, Chen Y, et al. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study[J]. BMJ Open, 2016, 6(12): e013509.
[1] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[2] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[3] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[4] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[5] 周东杰, 蒋敏, 范海瑞, 高玲玲, 孔祥, 卢丹, 王丽萍. 非编码RNA在卵泡发育成熟中作用及其机制的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 387-393.
[6] 陈荟竹, 郭应坤, 汪昕蓉, 宁刚, 陈锡建. 上皮性卵巢癌"二元论模型"的分子生物学研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 394-402.
[7] 韩春颖, 王婷婷, 李艳艳, 朴金霞. 子宫内膜癌患者淋巴管间隙浸润预测因素研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 403-409.
[8] 冯丹艳, 曹晓辉, 史玉霞. 血清脂联素与胎盘亮氨酸氨肽酶对妊娠期糖尿病患者妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 302-308.
[9] 邬龙海, 黄淼, 龚云辉, 喻云倩. 血清趋化因子在妊娠期糖尿病孕妇中的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 357-362.
[10] 刘艳艳, 谭曦, 彭雪. 妊娠合并膀胱低度恶性潜能乳头状尿路上皮肿瘤并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 212-218.
[11] 魏权, 张燊, 陈慧佳, 邹姮, 胡丽娜. 女性生殖道微生物群与辅助生殖技术相关性研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 151-155.
[12] 胡欧婵, 黄仲英. 不明原因复发性流产患者的治疗研究现状与展望[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 16-22.
[13] 邓荣珍, 罗宇珍, 赵若蓓, 邓杨, 廖蕴华, 潘玲. 血脂与IgA肾病患者肾脏预后的相关性研究[J]. 中华肾病研究电子杂志, 2023, 12(01): 13-19.
[14] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[15] 刘玉苓, 王婷婷, 吴高峰, 俞淑静. 健康体检人群内脏脂肪面积与新型炎症标志物的相关性研究[J]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 197-202.
阅读次数
全文


摘要